This contract award is for the delivery of FLUORESCITE 10% VIAL 5ML, a medical product, to the Defense Logistics Agency (DLA). The $12,104.74 firm fixed price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 26, 2024 with a performance completion date of December 27, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order falls under that larger IDC contract.
Generated 3/27/25, 9:42 AM